Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    U.S. Hotel Construction Shrinks Again for Ninth Consecutive Month

    October 23, 2025

    AWS Restores Services After Major Cloud Outage Disrupts Users Globally

    October 22, 2025

    Palantir, Snowflake’s Big AI Data Partnership Fails to Win Over Investors

    October 17, 2025
    Facebook X (Twitter) Instagram LinkedIn
    • About Us
    • Press Release
    Thursday, October 23
    Facebook X (Twitter) LinkedIn Instagram
    Business Leaders Review: Best Business Magazine and News OnlineBusiness Leaders Review: Best Business Magazine and News Online
    • Home
    • Magazines
    • Featured Leaders
    • Technology
      • Big Data
      • Artificial Intelligence
      • Robotics
      • Cloud
      • Cyber Security
      • Storage
      • IoT
      • Blockchain
      • Data Analytics
    • Industry
      • Banking & Finance
      • Construction
      • Digital Marketing
      • Economy
      • Education
      • EV Industry
      • Food & Beverage
      • Healthcare
      • Legal
      • Manufacturing
      • Mining & Metals
      • Pharmaceutical
    • Testimonials
    • Events
    • Blogs
    • Awards
    • Our Clients
    Business Leaders Review: Best Business Magazine and News OnlineBusiness Leaders Review: Best Business Magazine and News Online
    Home » GLP-1 and Weight-Loss Drugs May Curb Alcohol Cravings, Study Finds
    Healthcare

    GLP-1 and Weight-Loss Drugs May Curb Alcohol Cravings, Study Finds

    By Business Leaders ReviewMay 14, 2025

    Key Highlights

    • Alcohol intake dropped 68% in four months among regular drinkers using GLP-1 drugs like semaglutide and liraglutide.
    • Patients described the change as “effortless,” suggesting these drugs affect alcohol cravings at the brain level.
    • Findings mirror those of approved alcohol treatment drugs, but lacked a control group for comparison.

    New research suggests that popular weight-loss drugs like Ozempic (semaglutide) and Wegovy may also help significantly reduce alcohol consumption. In a recent study published in Diabetes, Obesity and Metabolism, participants taking GLP-1 drugs cut their alcohol intake by nearly two-thirds (68%) in just four months.

    GLP-1 drugs mimic a natural hormone that controls blood sugar, slows digestion, and reduces appetite. Researchers believe these drugs also suppress alcohol cravings by directly acting on the brain’s reward system.

    “These effects are described by patients as ‘effortless,’” said Dr. Carel le Roux of University College Dublin.

    Promising But Preliminary

    The study tracked 262 overweight or obese patients in Ireland who were prescribed either semaglutide or liraglutide. Among regular drinkers, alcohol use dropped dramatically, with results similar to nalmefene, a drug used to treat alcohol dependence in Europe.

    While promising, the study did not include a control group and involved a relatively small number of participants. Further clinical trials are needed to confirm whether GLP-1 drugs could be formally used to treat alcohol use disorder.Researchers shared the findings at the European Association for the Study of Obesity conference in Malaga, Spain.

    Related Posts

    U.S. Hotel Construction Shrinks Again for Ninth Consecutive Month

    October 23, 2025

    AWS Restores Services After Major Cloud Outage Disrupts Users Globally

    October 22, 2025

    Palantir, Snowflake’s Big AI Data Partnership Fails to Win Over Investors

    October 17, 2025

    China Blamed for Major Breach at U.S. Cybersecurity Giant F5, Reports Bloomberg

    October 17, 2025

    Pfizer CEO Urges US Pharma Industry to Partner with China

    October 16, 2025

    Stadler Boosts Production Speed with Panasonic’s Automated Robot Welding System

    October 15, 2025
    Top Posts

    U.S. Hotel Construction Shrinks Again for Ninth Consecutive Month

    October 23, 2025

    AWS Restores Services After Major Cloud Outage Disrupts Users Globally

    October 22, 2025

    Palantir, Snowflake’s Big AI Data Partnership Fails to Win Over Investors

    October 17, 2025
    Don't Miss

    U.S. Hotel Construction Shrinks Again for Ninth Consecutive Month

    October 23, 2025

    Key Highlights The U.S. hotel construction pipeline contracted for the ninth consecutive month, underscoring the…

    AWS Restores Services After Major Cloud Outage Disrupts Users Globally

    October 22, 2025

    Palantir, Snowflake’s Big AI Data Partnership Fails to Win Over Investors

    October 17, 2025

    China Blamed for Major Breach at U.S. Cybersecurity Giant F5, Reports Bloomberg

    October 17, 2025
    Stay In Touch
    • Facebook
    • Twitter
    • Instagram
    • LinkedIn
    About Us
    About Us

    Business Leaders Review is a global print and digital monthly and yearly magazine, which provides a platform to showcase business/tech leaders and their company’s profile from various sectors. Our aim is to publish the c-suite leaders stories.

    We are helping the leaders & readers to showcase their ideas and innovations to the business and tech world in this current market situation along with their awards and achievements. Doing so we hope to leverage thousands of businesses and personnel around the globe.

    Most Popular

    U.S. Hotel Construction Shrinks Again for Ninth Consecutive Month

    AWS Restores Services After Major Cloud Outage Disrupts Users Globally

    Palantir, Snowflake’s Big AI Data Partnership Fails to Win Over Investors

    Latest Magazines
    Facebook X (Twitter) LinkedIn Instagram
    • Home
    • Our Clients
    • TECHNLOGY NEWS
    • Industry News
    • Contact Us
    • Privacy Policy
    • Reprints and Permissions
    © 2021-2025 Business Leaders Review LLC | All Rights Reserved | Empowering Communication Globally

    Type above and press Enter to search. Press Esc to cancel.